What Is Zurzuvae®?
FDA-Approved Postpartum Depression Treatment
What is Zurzuvae®, you might ask? Zurzuvae®, also known by its generic name zuranolone, is a groundbreaking medication specifically approved to treat postpartum depression. Approved by the FDA on August 4, 2023, this once-daily pill is taken over a 14-day course. The mechanism of action of Zurzuvae® involves enhancing GABA-A receptors, which helps regulate the brain's calming pathways. Unlike traditional antidepressants, Zurzuvae® is not an SSRI. This makes zurzuvae/zuranolone a unique option for those who have not found relief with other treatments.
Proven Results: Zurzuvae®’s Impact on Postpartum Depression
Personalized Dosing and Administration of Zurzuvae®
Postpartum depression (PPD) is a significant mental health concern affecting one in 7 new moms. More than just the “baby blues”, symptoms can include persistent sadness, anxiety, crying episodes, feeling distant from baby, withdrawing from family and friends, and irritability.
So it’s good news that the Food and Drug Administration (FDA) recently approved the first oral medication specifically designed to treat PPD. This new 14-day medication is prescribed by your psychiatrist, psychiatric nurse practitioner or obstetrician-gynecologist in consultation with a psychiatrist or psychiatric nurse practitioner.
Benefits of Zurzuvae® for New Moms
There are a number of benefits. They include:
Fast acting: clinical trials show that Zurzuvae® can lead to significant improvements in symptoms within just three days, offering faster relief compared to traditional antidepressants, which may take several weeks to work.
Short treatment duration: the medication is administered once daily for 14 days, providing an easy and convenient treatment for new moms busy with baby.
Easier access: Zurzuvae® is an oral medication that can be taken at home, usually before bedtime.
What is Zurzuvae®'s generic name?
The generic name for Zurzuvae® is zuranolone.
Considerations and Side Effects
Is Zurzuvae® a controlled substance?
Common side effects reported during clinical trials include drowsiness, dizziness, and fatigue. Due to the sedative effects, it is recommended to take the medication in the evening. Additionally, while preliminary data suggest low transmission of Zurzuvae® through breast milk, moms should discuss the benefits and risks of breastfeeding while on medication with their OBGYN provider.
The approval of Zurzuvae® marks a significant advancement in the treatment of postpartum depression, offering a rapid and convenient option for new mothers struggling with this condition. As with any medication, it is essential for new moms to consult with their OBGYN provider to determine the most appropriate treatment plan tailored to individual needs.
Is Zurzuvae® a controlled substance?
Is Zurzuvae® a controlled substance?
Yes, it is classified as a Schedule IV controlled substance.
Contact Us
Cost and Access to Medication: The cost of the full 14-day course of zuranolone treatment is about $15,900.
Some but not all insurance companies cover the cost of zuranolone; there are also financial assistance programs, such as the Zurzuvae® Savings Card Program, that are available to help patients access zuranolone.
Another important thing to note is that a patient can’t just bring their prescription into the local pharmacy. The provider needs to submit a request to a specialty pharmacy.
Contact Us
Contact Us
If you have any questions or would like to schedule an appointment, please don't hesitate to contact us. We are here to support you on your journey towards mental wellness.
Insurance and Payment
Insurance and Payment
Insurance and Payment
We accept most insurance plans and offer a sliding scale fee for uninsured patients. We believe that everyone deserves access to quality mental health care, and we are committed to making our services accessible to all.